Annual Stockholder Meeting Results and Director Elections

AEON Biopharma held its Annual Meeting of Stockholders on June 17, 2026, where stockholders voted on two key proposals. The first proposal involved the election of Class III directors to the company's board. Marc Forth was elected with 13,297,322 votes for and 27,738 withheld, while Seongsoo Park was elected with 13,117,299 votes for and 207,761 withheld. Both directors will serve three-year terms ending at the 2029 Annual Meeting. The second proposal ratified the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, which passed with 21,502,418 votes for, 18,217 against, and 1,498 abstentions. The meeting results were certified by the company's inspector of elections and represent routine corporate governance matters.